Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

High rates of Staphylococcus aureus USA400 infection, Northern Canada.

Golding GR, Levett PN, McDonald RR, Irvine J, Quinn B, Nsungu M, Woods S, Khan M, Ofner-Agostini M, Mulvey MR; Northern Antibiotic Resistance Partnership.

Emerg Infect Dis. 2011 Apr;17(4):722-5. doi: 10.3201/eid1704.100482.

2.

Risk factors for and outcomes associated with clinical isolates of Escherichia coli and Klebsiella species resistant to extended-spectrum cephalosporins among patients admitted to Canadian hospitals.

Ofner-Agostini M, Simor A, Mulvey M, McGeer A, Hirji Z, McCracken M, Gravel D, Boyd D, Bryce E.

Can J Infect Dis Med Microbiol. 2009 Fall;20(3):e43-8.

3.

Longitudinal phylogenetic surveillance identifies distinct patterns of cluster dynamics.

Ragonnet-Cronin M, Ofner-Agostini M, Merks H, Pilon R, Rekart M, Archibald CP, Sandstrom PA, Brooks JI.

J Acquir Immune Defic Syndr. 2010 Sep;55(1):102-8. doi: 10.1097/QAI.0b013e3181e8c7b0.

PMID:
20622676
4.

A comparison of risk factors associated with community-associated methicillin-resistant and -susceptible Staphylococcus aureus infections in remote communities.

Golding GR, Levett PN, McDonald RR, Irvine J, Nsungu M, Woods S, Horbal A, Siemens CG, Khan M, Ofner-Agostini M, Mulvey MR; Northern Antibiotic Resistance Partnership (NARP).

Epidemiol Infect. 2010 May;138(5):730-7. doi: 10.1017/S0950268809991488. Epub 2010 Jan 22.

PMID:
20092664
5.

A cross-sectional study of maternity care providers' and women's knowledge, attitudes, and behaviours towards influenza vaccination during pregnancy.

Tong A, Biringer A, Ofner-Agostini M, Upshur R, McGeer A.

J Obstet Gynaecol Can. 2008 May;30(5):404-10.

PMID:
18505664
6.

Investigation of the second wave (phase 2) of severe acute respiratory syndrome (SARS) in Toronto, Canada. What happened?

Ofner-Agostini M, Wallington T, Henry B, Low D, McDonald LC, Berger L, Mederski B; SARS Investigative Team, Wong T.

Can Commun Dis Rep. 2008 Feb;34(2):1-11. English, French.

7.

Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005.

Ofner-Agostini M, Johnston BL, Simor AE, Embil J, Matlow A, Mulvey M, Ormiston D, Conly J; Canadian Nosocomial Infection Surveillance Program.

Infect Control Hosp Epidemiol. 2008 Mar;29(3):271-4. doi: 10.1086/528812.

PMID:
18241031
8.

The emerging epidemiology of VRE in Canada: results of the CNISP Passive Reporting Network, 1994 to 1998.

Conly JM, Ofner-Agostini M, Paton S, Johnston L, Mulvey M, Kureishi A, Nicolle L, Matlow A; Canadian Hospital Epidemiology Commmittee; Canadian Nosocomial Infection Surveillance Program.

Can J Infect Dis. 2001 Nov;12(6):364-70.

9.

N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project.

Hyland M, Ofner-Agostini M, Miller M, Paton S, Gourdeau M, Ishak M; Canadian Hospital Epidemiology Committee; Canadian Nosocomial Infection Surveillance Program (Health Canada).

Can J Infect Dis. 2001 Mar;12(2):81-8.

10.

Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals.

Ofner-Agostini M, Varia M, Johnston L, Green K, Simor A, Amihod B, Bryce E, Henderson E, Stegenga J, Bergeron F; Canadian Nosocomial Infection Surveillance Program, Gravel D.

Am J Infect Control. 2007 Nov;35(9):563-8.

PMID:
17980232
11.

Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.

Simor AE, Stuart TL, Louie L, Watt C, Ofner-Agostini M, Gravel D, Mulvey M, Loeb M, McGeer A, Bryce E, Matlow A; Canadian Nosocomial Infection Surveillance Program.

Antimicrob Agents Chemother. 2007 Nov;51(11):3880-6. Epub 2007 Aug 27.

12.

A point prevalence survey of health care-associated infections in pediatric populations in major Canadian acute care hospitals.

Gravel D, Matlow A, Ofner-Agostini M, Loeb M, Johnston L, Bryce E, Sample ML, Roth VR, Goldman C, Taylor G; Canadian Nosocomial Infection Surveillance Program.

Am J Infect Control. 2007 Apr;35(3):157-62.

PMID:
17433938
13.

ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.

Tracz DM, Boyd DA, Hizon R, Bryce E, McGeer A, Ofner-Agostini M, Simor AE, Paton S, Mulvey MR; Canadian Nosocomial Infection Surveillance Program.

FEMS Microbiol Lett. 2007 May;270(2):265-71. Epub 2007 Feb 26.

14.

Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners.

Barton M, Hawkes M, Moore D, Conly J, Nicolle L, Allen U, Boyd N, Embree J, Van Horne L, Le Saux N, Richardson S, Moore A, Tran D, Waters V, Vearncombe M, Katz K, Weese JS, Embil J, Ofner-Agostini M, Ford-Jones EL; Writing Group of the Expert Panel of Canadian Infectious Disease, Infection Prevention and Control, and Public Health Specialists.

Can J Infect Dis Med Microbiol. 2006 Sep;17 Suppl C:4C-24C. No abstract available.

15.

Cluster of cases of severe acute respiratory syndrome among Toronto healthcare workers after implementation of infection control precautions: a case series.

Ofner-Agostini M, Gravel D, McDonald LC, Lem M, Sarwal S, McGeer A, Green K, Vearncombe M, Roth V, Paton S, Loeb M, Simor A.

Infect Control Hosp Epidemiol. 2006 May;27(5):473-8. Epub 2006 Apr 26.

PMID:
16671028
16.

Methicillin-resistant Staphylococcus aureus in Canadian aboriginal people.

Ofner-Agostini M, Simor AE, Mulvey M, Bryce E, Loeb M, McGeer A, Kiss A, Paton S; Canadian Nosocomial Infection Surveillance Program, Health Canada.

Infect Control Hosp Epidemiol. 2006 Feb;27(2):204-7. Epub 2006 Feb 8.

PMID:
16465642
17.

Clinical and epidemiologic features of methicillin-resistant Staphylococcus aureus in elderly hospitalized patients.

Simor AE, Ofner-Agostini M, Paton S, McGeer A, Loeb M, Bryce E, Mulvey M; Canadian Nosocomial Infection Surveillance Program.

Infect Control Hosp Epidemiol. 2005 Oct;26(10):838-41.

PMID:
16276960
18.

Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals.

Mulvey MR, Bryce E, Boyd DA, Ofner-Agostini M, Land AM, Simor AE, Paton S.

Antimicrob Agents Chemother. 2005 Jan;49(1):358-65.

19.

Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals.

Mulvey MR, Bryce E, Boyd D, Ofner-Agostini M, Christianson S, Simor AE, Paton S; Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program, Health Canada.

Antimicrob Agents Chemother. 2004 Apr;48(4):1204-14.

20.

Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance, 1995-1999.

Simor AE, Ofner-Agostini M, Bryce E, McGeer A, Paton S, Mulvey MR; Canadian Hospital Epidemiology Committee and Canadian Nosocomial Infection Surveillance Program, Health Canada.

J Infect Dis. 2002 Sep 1;186(5):652-60. Epub 2002 Aug 9.

PMID:
12195352
21.

Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals.

Miller MA, Hyland M, Ofner-Agostini M, Gourdeau M, Ishak M; Canadian Hospital Epidemiology Committee. Canadian Nosocomial Infection Surveillance Program.

Infect Control Hosp Epidemiol. 2002 Mar;23(3):137-40.

PMID:
11918118
22.

The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance.

Simor AE, Ofner-Agostini M, Bryce E, Green K, McGeer A, Mulvey M, Paton S; Canadian Nosocomial Infection Surveillance Program, Health Canada.

CMAJ. 2001 Jul 10;165(1):21-6.

23.

Identification of the first vancomycin-resistant Enterococcus faecalis harbouring vanE in Canada.

Van Caeseele P, Giercke S, Wylie J, Boyd D, Mulvey M, Amin S, Ofner-Agostini M.

Can Commun Dis Rep. 2001 Jun 15;27(12):101-4. English, French. No abstract available.

24.
25.

Vancomycin-resistant enterococci (VRE) in Canada - Results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE point prevalence surveillance project.

Ofner-Agostini ME, Conly J, Paton S, Kureishi A, Nicolle L, Mulvey M, Johnson W, Johnston L; Canadian Hospital Epidemiology Committee.

Can J Infect Dis. 1997 Mar;8(2):73-8. No abstract available.

Supplemental Content

Loading ...
Support Center